Transition of children with membranoproliferative glomerulonephritis to adolescence and adulthood
- PMID: 18175061
- DOI: 10.1007/s10157-007-0014-5
Transition of children with membranoproliferative glomerulonephritis to adolescence and adulthood
Abstract
Background: Many chronic renal diseases in children, including membranoproliferative glomerulonephritis (MPGN), often continue into adulthood, and these patients require continuing management. Despite the importance of the topic, there has been limited discussion about the problems of transition in children with continuing renal disease. We report our experience in patients with MPGN, as they matured from childhood to adolescence and adulthood, so-called "carry-over" cases.
Methods: The clinical course of diffuse MPGN in 27 children was retrospectively reviewed. Patients were over 18 years old at the end of follow-up.
Results: The mean follow-up period was 12.6 years; 20 children (74%) were identified by school urinary screening. The clinical course was favorable, and none of the patients progressed to end-stage renal failure during follow-up. However, eight patients (30%) continued to demonstrate proteinuria; two patients were nephrotic. Four patients were non-compliant and discontinued medication by themselves. Three patients were still on low dose of alternate-day (ALD) prednisolone. Twenty patients finished the treatment and were followed for an average of 4.6 years. Only one demonstrated trace amounts of proteinuria 1 year after discontinuing ALD prednisolone.
Conclusions: MPGN often continues during maturation from childhood to adulthood, and patients are usually referred to adult nephrologists. Good communication between pediatric and adult nephrologists is important. In addition, more in depth explanation and reeducation about their disease and its management are helpful when these patients reach adolescence. These measures will improve their care and help to assure compliance with their medication regimen.
Similar articles
-
Comparison of pulse and oral steroid in childhood membranoproliferative glomerulonephritis.J Nephrol. 2007 Mar-Apr;20(2):234-45. J Nephrol. 2007. PMID: 17514629 Clinical Trial.
-
Idiopathic membranoproliferative glomerulonephritis in Japanese children.Pediatr Nephrol. 1995 Jun;9(3):272-7. doi: 10.1007/BF02254182. Pediatr Nephrol. 1995. PMID: 7632509
-
Long-term clinical and morphological evaluation of primary membranoproliferative glomerulonephritis.Zhonghua Yi Xue Za Zhi (Taipei). 1996 Jan;57(1):34-41. Zhonghua Yi Xue Za Zhi (Taipei). 1996. PMID: 8820034
-
Management of membranoproliferative glomerulonephritis: evidence-based recommendations.Kidney Int Suppl. 1999 Jun;70:S41-6. doi: 10.1046/j.1523-1755.1999.07006.x. Kidney Int Suppl. 1999. PMID: 10369194 Review.
-
[Membranoproliferative glomerulonephritis].Nihon Rinsho. 2004 Oct;62(10):1849-55. Nihon Rinsho. 2004. PMID: 15500129 Review. Japanese.
Cited by
-
Why is transition between child and adult services a dangerous time for young people with chronic kidney disease? A mixed-method systematic review.PLoS One. 2018 Aug 2;13(8):e0201098. doi: 10.1371/journal.pone.0201098. eCollection 2018. PLoS One. 2018. PMID: 30071028 Free PMC article.
-
Transition of Chronic Pediatric Nephrological Patients to Adult Care Excluding Patients on Renal Replacement Therapy with Literature Review.Children (Basel). 2022 Jun 26;9(7):959. doi: 10.3390/children9070959. Children (Basel). 2022. PMID: 35883943 Free PMC article.
References
MeSH terms
LinkOut - more resources
Full Text Sources